REKLAMA

KRKA: Share buy-back programme schedule from January to June 2027

2026-11-18 12:21
publikacja
2026-11-18 12:21
Dodaj Bankier.pl w Google
Spis treści:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Share buy-back programme schedule from January to June 2027.pdf

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

51

/

2026

Date of issue:

2026-11-18

Short name of the issuer

KRKA

Subject

Share buy-back programme schedule from January to June 2027

Official market - legal basis

Unofficial market - legal basis

Contents of the report:

Based on the provisions of Article 26 of the Ljubljana Stock Exchange Rules, Article 158 of the Market in Financial Instruments Act, Article 2 of the Commission Delegated regulation (EU) No 2016/1052 and Article 17 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto (hereinafter: Krka) discloses information regarding share buy-back programme schedule from January to June 2027.

Krka disclosed the start of the share buy-back programme on 20 July 2026 through the electronic dissemination system SEOnet.

The programme schedule for H1 2027 is attached.

The public will be regularly informed about these acquisitions of treasury shares.

This announcement will be published on the company’s website (www.krka.biz) starting from 18 November 2026 for a minimum period of 5 years.

Annexes

File

Description

Share buy-back programme schedule from January to June 2027.pdf

Share buy-back programme schedule from January to June 2027

Legal framework

Type of information

TRANSD

Acquisition or disposal of an issuer’s own shares

RegulatoryData

Collection Body

PLKNF

Unique data record identifier

Type of submission

New (to be used for new information)

Voluntary information flag

Date or period covered [Date or beginning of the period to which the information relates]

2027-01-01

Date or period covered [Date or end of the period to which the information relates]

2027-06-30

Personal data flag

Macierzyste państwo członkowskie, w stosownych przypadkach

PL

DocumentReference

Język, w którym przekazano informacje

Oryginał (ORIG) czy tłumaczenie (TRAN)

Numer referencyjny pliku danych

PL

ORIG

SubmittingEntity

Submitting entity LEI

or

Submitting entity name - natural person

RelatedEntity/LegalPerson

Entity LEI

Size of the entity

Industry sector(s)

549300H9RLRTRTLRUZ73

Large group

(acc. NACE): C

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

6

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date

Name

Position / Function

Signature

2026-11-18

Jože Colarič

President of the Management Board and CEO

Najlepsze produkty finansowe znajdziesz w naszej porównywarce - SPRAWDŹ
Źródło:Komunikaty spółek (ESPI)
Tematy
Energooszczędny dom lub mieszkanie? Bank Millennium ma teraz ciekawą propozycję
Energooszczędny dom lub mieszkanie? Bank Millennium ma teraz ciekawą propozycję

Komentarze (0)

dodaj komentarz

Powiązane:

Polecane

Najnowsze

Popularne

Ważne linki